Navigation Links
Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
Date:6/17/2008

the three. A recent market research report by Kalorama Information details the emergence of honey-based dressings as a growing sub-category within active dressings.

About Derma Sciences

Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. Derma has two products in development: the NIMBUS technology based line of barrier gauze dressings, and DSC127, the company's novel angiotensin analog for accelerated wound healing and scar reduction. The barrier technology was licensed from Quick-Med in Q1 of 2007 and is pending its initial FDA marketing clearance. DSC127 was licensed from The University of Southern California in Q4 of 2007 and is entering into a Phase II study, with anticipated initial patient enrollment to begin in Q3 of 2008. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.

About the Journal of Wound Care (JWC)

JWC is the definitive wound-care journal and the leading source of tissue viability research and clinical information. Launched in 1992, it is designed to meet the needs of the multidisciplinary team. The journal is essential reading for all wound-care specialists - nurses, doctors and researchers -- who are keen to keep up-to-date with all developments in wound management and tissue viability, but also appeals to generalists wishing to enhance their practice. JWC is internationally renowned for its cutting edge and state-of-the-art research and practice articles. The
'/>"/>

SOURCE Derma Sciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
2. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
3. Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
4. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
5. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
6. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
7. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
10. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
11. Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Tianyin Pharmaceutical Co., ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today announced that the Company achieved the Public ... Practice (GMP) certificate of TPI,s Qionglai Facility (QLF) ... The public notice period is a significant procedure ...
(Date:12/22/2014)... NxStage Medical, Inc. (NASDAQ: NXTM ... announced today that the U.S. Food and Drug ... perform hemodialysis overnight while the patient is at ... System One is the first and only hemodialysis ... Home nocturnal hemodialysis is an ...
(Date:12/22/2014)... , Dec. 22, 2014  ConvaTec, a privately-held ... Moraviec has been appointed Interim Chief Executive Officer of ... Moraviec succeeds Ken Berger .  "The Board of ... in leading ConvaTec over the past three years," said ... of Directors.  "We are confident that the company is ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... Oct. 18, 2011 Octapharma USA ... over the next few months, including AABB,s 64th Annual ... 25 and National Hemophilia Foundation,s (NHF) 63rd Annual Meeting ... In December, Octapharma USA will also participate in the ...
... Oct. 18, 2011 For thousands of nurses, lab technicians, ... of shopping for the latest in scrub fashions that are ... on the success of the 10 original stores that launched ... to open in Tampa, Orlando and Miami FL; Rochester and ...
Cached Medicine Technology:Octapharma USA to Participate in Important Medical Meetings at AABB, NHF, ASHP and ASH 2Octapharma USA to Participate in Important Medical Meetings at AABB, NHF, ASHP and ASH 3Octapharma USA to Participate in Important Medical Meetings at AABB, NHF, ASHP and ASH 4An RX for Busy Healthcare Professionals 2An RX for Busy Healthcare Professionals 3
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a comprehensive ... and marketing of a series of induction heating equipment. ... series of induction brazing equipments . , According ... brazing refers to the joining of two or ... The manager says that there are fundamental differences in ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
(Date:12/25/2014)... When head lice hits a home or school, parents and ... of it while keeping it from taking over the house ... solution right in their neighborhood: Lice Troopers . Expanding ... spectrum head lice screening and treatment services to families and ... Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , The ...
(Date:12/25/2014)... early stage breast cancer patients who undergo chemotherapy and/or ... eventually develop leukemia as a result of their treatment, ... a review of more than 20,000 breast cancer cases ... the risk for developing treatment-related leukemia, though low, is ... frequency of bone marrow cancers such as leukemia is ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... , , , HATBORO, Pa., ... a leading technology provider of enterprise mobility solutions for the healthcare ... panel discussion as part of Mobile Monday Mid-Atlantic, Monday September 21, ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO ) ...
... , , , ... NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic ... financing with institutional and other accredited investors, including members of ... half of the offering. Gross proceeds of approximately $2.9 million ...
... HLTH Corporation (Nasdaq: HLTH ) today announced that ... segment to affiliates of Aurora Capital Group, a Los Angeles based ... the fourth quarter and is subject to customary closing conditions, including ... Act. , , The purchase price of ...
... Sept. 18 NBTY, Inc. (NYSE: NTY ) ( ... today announced that it will web cast presentations by Harvey Kamil, President ... , , Mr. Kamil,s presentation at the ... 2009 will be web cast at 4:30 PM Eastern Time that day. ...
... , , CLEVELAND, Sept. ... 45-minute seminar that highlights the critical need for long-term care insurance ... available. It will be held at multiple times in 4 Ohio ... , , *(PHOTO 72dpi: Send2Press.com/mediaboom/09-0910-3in4ltc_72dpi.jpg) ...
... , , , ... www.maxhealthcare.in ) and Perot Systems Corporation (NYSE: PER ... which Perot Systems will provide IT outsourcing (ITO) and electronic health records ... in the Indian healthcare industry as well as the company,s first India-based ...
Cached Medicine News:Health News:InfoLogix to Present 'Mobile in the Enterprise: Keeping up with User Demand While Containing Costs' at Mobile Monday Panel in Philadelphia 2Health News:InfoLogix to Present 'Mobile in the Enterprise: Keeping up with User Demand While Containing Costs' at Mobile Monday Panel in Philadelphia 3Health News:NewCardio Completes $2.9 Million Private Placement 2Health News:NewCardio Completes $2.9 Million Private Placement 3Health News:NewCardio Completes $2.9 Million Private Placement 4Health News:HLTH Corporation Announces Agreement to Sell Porex Unit to Aurora Capital Group for $142 Million 2Health News:HLTH Corporation Announces Agreement to Sell Porex Unit to Aurora Capital Group for $142 Million 3Health News:NBTY to Web Cast Presentations at UBS Global Life Sciences Conference and Canaccord Adams Healthy Living Conference 2Health News:NBTY to Web Cast Presentations at UBS Global Life Sciences Conference and Canaccord Adams Healthy Living Conference 3Health News:Long Term Care Seminars in Dayton, Cleveland, Cincinnati, and Columbus -- Free to Public 2Health News:Long Term Care Seminars in Dayton, Cleveland, Cincinnati, and Columbus -- Free to Public 3Health News:Max Healthcare of India Selects Perot Systems for Over Rs. 90 Crores ($18 Million) 10-year IT Services and Electronic Health Records Implementation 2Health News:Max Healthcare of India Selects Perot Systems for Over Rs. 90 Crores ($18 Million) 10-year IT Services and Electronic Health Records Implementation 3Health News:Max Healthcare of India Selects Perot Systems for Over Rs. 90 Crores ($18 Million) 10-year IT Services and Electronic Health Records Implementation 4Health News:Max Healthcare of India Selects Perot Systems for Over Rs. 90 Crores ($18 Million) 10-year IT Services and Electronic Health Records Implementation 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: